Ehrenkranz Partners L.P. bought a new position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 701 shares of the company’s stock, valued at approximately $753,000. Eli Lilly and Company […]

Bamco Inc. NY boosted its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 1.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 86,476 shares of the company’s stock after purchasing an additional 863 shares during the quarter. Bamco Inc. NY’s holdings […]

Castle Hook Partners LP lessened its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 3.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 383,550 shares of the company’s stock after selling 15,509 shares during the period. Eli Lilly and […]

Vestcor Inc reduced its stake in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 18.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 23,446 shares of the company’s stock after selling 5,282 shares during the quarter. […]